NCT07763210 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT07763210
Title	Intrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin Lymphoma
Recruitment	Recruiting
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Vanderbilt-Ingram Cancer Center
Indications	diffuse large B-cell lymphoma follicular lymphoma mantle cell lymphoma marginal zone lymphoma non-Hodgkin lymphoma high-grade B-cell lymphoma double-hit/triple-hit primary mediastinal B-cell lymphoma
Therapies	Cytarabine + Dexamethasone + Hydrocortisone Cyclophosphamide + Dexamethasone Cytarabine + Hydrocortisone + Methylprednisolone axicabtagene ciloleucel Brexucabtagene autoleucel
Age Groups:	adult \| senior
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
Vanderbilt University/Ingram Cancer Center	RECRUITING	Nashville	Tennessee	37203	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT07763210Clinical Trial Detail